127
Participants
Start Date
Not specified
Study Completion Date
December 31, 2005
Selegiline hydrochloride
Beth Israel Med. Ctr., ACTU, New York
Columbia Univ., HIV Prevention and Treatment Medical Ctr., New York
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Johns Hopkins Adult AIDS CRS, Baltimore
Unc Aids Crs, Chapel Hill
Northwestern University CRS, Chicago
Cook County Hosp. CORE Ctr., Chicago
UCLA CARE Center CRS, Los Angeles
Ucsd, Avrc Crs, San Diego
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Washington AIDS CRS, Seattle
Massachusetts General Hospital ACTG CRS, Boston
Washington U CRS, St Louis
The Miriam Hosp. ACTG CRS, Providence
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Neurologic AIDS Research Consortium (NARC)
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH